Published in Proc Natl Acad Sci U S A on July 01, 1975
Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev (1995) 7.40
Reconstitution of Semliki forest virus membrane. J Cell Biol (1977) 3.68
Molecular nature of the complement lesion. Proc Natl Acad Sci U S A (1978) 2.09
The eucaryotic aminoacyl-tRNA synthetase complex: suggestions for its structure and function. J Cell Biol (1984) 1.61
Lateral diffusion of rhodopsin in photoreceptor cells measured by fluorescence photobleaching and recovery. Biophys J (1981) 1.60
Differential effects of permeating and nonpermeating solutes on the fatty acid composition of Pseudomonas putida. Appl Environ Microbiol (2000) 1.18
Rate of lateral diffusion of intramembrane particles: measurement by electrophoretic displacement and rerandomization. Proc Natl Acad Sci U S A (1981) 1.11
Lateral diffusion of visual pigments in toad (Bufo marinus) rods and in catfish (Ictalurus punctatus) cones. J Physiol (1990) 1.07
Lateral diffusion in model membranes is independent of the size of the hydrophobic region of molecules. Biophys J (1993) 1.04
Lateral diffusion of lipids and glycophorin in solid phosphatidylcholine bilayers. The role of structural defects. Biophys J (1984) 1.00
Lateral diffusion of lipid probes in the surface membrane of human platelets. An electron-electron double resonance (ELDOR) study. Biophys J (1986) 0.97
Bilayer structure and physical dynamics of the cytochrome b5 dimyristoylphosphatidylcholine interaction. Biophys J (1992) 0.82
Effect of cerulenin on macromolecule synthesis in chemoheterotrophically and photoheterotrophically grown Rhodopseudomonas sphaeroides. J Bacteriol (1983) 0.82
Relationship between the density distribution of intramembrane particles and electron transfer in the mitochondrial inner membrane as revealed by cholesterol incorporation. J Cell Biol (1982) 0.78
Rapid conformational changes of cytochrome P-450: effect of dimyristoyl lecithin. Proc Natl Acad Sci U S A (1978) 0.77
Spatiotemporal pattern formation in thin layers and membranes: critical focal size. Proc Natl Acad Sci U S A (1978) 0.75
Lateral diffusion of rhodopsin in the photoreceptor membrane. Nature (1974) 11.38
Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry (1969) 5.98
Calorimetric studies of dilute aqueous suspensions of bilayers formed from synthetic L- -lecithins. J Biol Chem (1972) 3.49
A form of cytochrome b5 that contains an additional hydrophobic sequence of 40 amino acid residues. Proc Natl Acad Sci U S A (1971) 3.28
A form of reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase containing both the catalytic site and an additional hydrophobic membrane-binding segment. J Biol Chem (1973) 1.84
The self-diffusion coefficients of myoglobin and hemoglobin in concentrated solutions. J Biol Chem (1972) 1.82
Kinetics of the crystalline-liquid crystalline phase transition of dimyristoyl L-alpha-lecithin bilayers. Proc Natl Acad Sci U S A (1974) 1.56
Lipid-protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase system. J Biol Chem (1973) 1.49
The effect of ultrasonic irradiation on the chemical structure of egg lecithin. Biochem Biophys Res Commun (1971) 1.31
Evidence for randon distribution and translational movement of cytochrome b5 in endoplasmic reticulum. J Biol Chem (1974) 1.04
The binding of reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase to hepatic microsomes. J Biol Chem (1974) 0.88
The binding of cytochrome b5 to phosphatidylcholine vesicle. Biochem Biophys Res Commun (1973) 0.87
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int (2008) 4.73
Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res (1998) 3.65
Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther (2001) 3.59
Construction of the mycoplasma evolutionary tree from 5S rRNA sequence data. Proc Natl Acad Sci U S A (1985) 3.38
A form of cytochrome b5 that contains an additional hydrophobic sequence of 40 amino acid residues. Proc Natl Acad Sci U S A (1971) 3.28
Purification and properties of rat liver microsomal stearyl coenzyme A desaturase. Proc Natl Acad Sci U S A (1974) 3.18
Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature (1995) 2.78
Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem (1976) 2.77
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A (1999) 2.66
Bisphosphonates: from the laboratory to the clinic and back again. Bone (1999) 2.55
Anticodon and acceptor stem nucleotides in tRNA(Gln) are major recognition elements for E. coli glutaminyl-tRNA synthetase. Nature (1991) 2.39
Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. Proc Natl Acad Sci U S A (1996) 2.35
Identification of the NH2-terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain. J Biol Chem (1984) 2.14
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol (1997) 2.14
Construction and sequence of cDNA for rat liver stearyl coenzyme A desaturase. J Biol Chem (1986) 2.11
A form of reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase containing both the catalytic site and an additional hydrophobic membrane-binding segment. J Biol Chem (1973) 1.84
Plasmodium: genus-conserved primers for species identification and quantitation. Exp Parasitol (1995) 1.81
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro. J Bone Miner Res (1997) 1.72
The binding of cytochrome b 5 to liver microsomes. J Biol Chem (1972) 1.71
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
The cytoplasmic ribosomal RNAs of Plasmodium spp. Parasitol Today (1995) 1.56
Cytochrome b5 reduction by NADPH-cytochrome P-450 reductase. J Biol Chem (1979) 1.52
Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci U S A (1979) 1.52
Inhibition of Plasmodium falciparum protein synthesis. Targeting the plastid-like organelle with thiostrepton. J Biol Chem (1997) 1.51
Lipid-protein interactions in the reconstitution of the microsomal reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase system. J Biol Chem (1973) 1.49
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs. Mol Pharmacol (1999) 1.48
A Spiroplasma tRNA gene cluster. Isr J Med Sci (1984) 1.44
The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res (1998) 1.39
Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des (2010) 1.37
The binding of cytochrome b5 to phospholipid vesicles and biological membranes. Effect of orientation on intermembrane transfer and digestion by carboxypeptidase Y. J Biol Chem (1979) 1.36
Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages. J Bone Miner Res (1998) 1.36
Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro. Bone (2001) 1.35
Regulation and trafficking of three distinct 18 S ribosomal RNAs during development of the malaria parasite. J Mol Biol (1997) 1.33
Purification of cytochrome b5. Methods Enzymol (1978) 1.32
Intramembrane position of the fluorescent tryptophanyl residue in membrane-bound cytochrome b5. Biochemistry (1979) 1.32
Recognition of bases in Escherichia coli tRNA(Gln) by glutaminyl-tRNA synthetase: a complete identity set. EMBO J (1992) 1.31
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. Arthritis Rheum (2001) 1.31
Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporos Int (1999) 1.31
The induction and characterization of rat liver stearyl-CoA desaturase mRNA. J Biol Chem (1985) 1.31
The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res (1999) 1.30
Identification of a novel phosphonocarboxylate inhibitor of Rab geranylgeranyl transferase that specifically prevents Rab prenylation in osteoclasts and macrophages. J Biol Chem (2001) 1.22
The restricted tryptic cleavage of cytochrome b5. J Biol Chem (1966) 1.20
Intramembrane positions of membrane-bound chromophores determined by excitation energy transfer. Biochemistry (1979) 1.16
Orientation of the carboxyl and NH2 termini of the membrane-binding segment of cytochrome b5 on the same side of phospholipid bilayers. J Biol Chem (1981) 1.15
The nucleotide sequence of the 5S rRNA from Spiroplasma species BC3 and Mycoplasma mycoides sp. capri PG3. Nucleic Acids Res (1982) 1.10
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem (2000) 1.08
Complete amino acid sequence of steer liver microsomal NADH-cytochrome b5 reductase. J Biol Chem (1985) 1.06
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma. Br J Haematol (2000) 1.06
Competition of aminoacyl-tRNA synthetases for tRNA ensures the accuracy of aminoacylation. Nucleic Acids Res (1992) 1.05
Effects of interruption of apicoplast function on malaria infection, development, and transmission. Mol Biochem Parasitol (2000) 1.05
Evidence for randon distribution and translational movement of cytochrome b5 in endoplasmic reticulum. J Biol Chem (1974) 1.04
Synthetase competition and tRNA context determine the in vivo identify of tRNA discriminator mutants. J Mol Biol (1992) 1.04
Structural and functional properties of the membrane binding segment of cytochrome b5. J Biol Chem (1978) 1.04
Transfer RNA-dependent cognate amino acid recognition by an aminoacyl-tRNA synthetase. EMBO J (1996) 1.03
Qa alloantigen expression on functional T lymphocytes from spleen and thymus. Immunogenetics (1986) 1.02
The role of prenylated small GTP-binding proteins in the regulation of osteoclast function. Calcif Tissue Int (2002) 1.00
Proton magnetic resonance determination of the relative heme orientations in disordered native and reconstituted ferricytochrome b5. Assignment of heme resonances by deuterium labeling. J Biol Chem (1981) 1.00
Characterization of the interaction of amphipathic cytochrome b5 with stearyl coenzyme A desaturase and NADPH:cytochrome P-450 reductase. J Biol Chem (1980) 1.00
Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens. Adv Cancer Res (1980) 1.00
Combined study to assess the role of calcium alginate swabs and ligation of the inferior tonsillar pole in the control of intra-operative blood loss during tonsillectomy. J Laryngol Otol (1991) 0.99
Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrance of an R-MuLV-induced leukemia. Int J Cancer (1978) 0.99
Cytochrome b5 and cytochrome b5 reductase-phospholipid vesicles. Intervesicle protein transfer and oreintation factors in protein-protein interactions. J Biol Chem (1977) 0.98
The nucleotide sequence of a tRNA gene cluster from Spiroplasma meliferum. Nucleic Acids Res (1986) 0.97
Role of tyrosyl and arginyl residues in rat liver microsomal stearylcoenzyme A desaturase. Biochemistry (1978) 0.97
Interaction of halide ions with Aspergillus niger glucose oxidase. Biochemistry (1971) 0.97
Plasmodium: the developmentally regulated ribosome. Exp Parasitol (1994) 0.95
Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs. Mol Pharmacol (1998) 0.95
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. Eur J Pharm Sci (1999) 0.94
Subcellular distribution of the tumor-specific transplantation antigen of simian virus 40-transformed cells. J Natl Cancer Inst (1977) 0.94
Purification of stearyl-CoA desaturase from liver. Methods Enzymol (1978) 0.94
A novel method for efficient generation of transfected human osteoclasts. Calcif Tissue Int (2007) 0.94
Comparison of MHC genes among distantly related members of the genus Mus. J Immunol (1985) 0.93
The interaction of NADH-cytochrome b5 reductase and cytochrome b5 bound to egg lecithin liposomes. J Biol Chem (1975) 0.93
Protein and coenzyme interactions in the NADH-cytochrome b5 reductase system. Fed Proc (1966) 0.93
Correction of the amino acid sequence of calf liver microsomal cytochrome b5. J Biol Chem (1969) 0.92
Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry. J Chromatogr B Biomed Sci Appl (1997) 0.91
The characterization and interconversions of two conformational states of cytochrome b5 reductase. J Biol Chem (1971) 0.91
Biochemical analysis of a 40,000 mol. wt mouse serum protein which binds beta 2-microglobulin and has serological cross-reactivity with H-2 antigens. Mol Immunol (1982) 0.91
Connecting anticodon recognition with the active site of Escherichia coli glutaminyl-tRNA synthetase. J Mol Biol (1994) 0.90
The primary structure of the nonpolar segment of bovine cytochrome b5. J Biol Chem (1978) 0.90
A second dihydroorotate dehydrogenase (Type A) of the human pathogen Enterococcus faecalis: expression, purification, and steady-state kinetic mechanism. Arch Biochem Biophys (2000) 0.90
Mutant enzymes and tRNAs as probes of the glutaminyl-tRNA synthetase: tRNA(Gln) interaction. Biochimie (1991) 0.90
Topography of the C terminus of cytochrome b5 tightly bound to dimyristoylphosphatidylcholine vesicles. J Biol Chem (1987) 0.90
The binding of reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase to hepatic microsomes. J Biol Chem (1974) 0.88
Modification and identification of cytochrome b5 carboxyl groups involved in protein-protein interaction with cytochrome b5 reductase. J Biol Chem (1979) 0.88
Osteoclasts on bone and dentin in vitro: mechanism of trail formation and comparison of resorption behavior. Calcif Tissue Int (2013) 0.87
The effect of heme binding on the tryptophan residue and the protein conformation of cytochrome b 5 . J Biol Chem (1972) 0.87
Identification of the essential cysteine residue of NADH-cytochrome b5 reductase. J Biol Chem (1986) 0.87
Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor. Proc Natl Acad Sci U S A (1979) 0.87
The heme-binding properties of prostaglandin synthetase from sheep vesicular gland. J Biol Chem (1981) 0.86
Escherichia coli tryptophanyl-tRNA synthetase mutants selected for tryptophan auxotrophy implicate the dimer interface in optimizing amino acid binding. Biochemistry (1996) 0.86
The reactivity of the lysyl residues of cytochrome b5. J Biol Chem (1966) 0.86